Cash Converters FY26 slides: luxury pivot drives record revenue

Cash Converters (ASX:CCV) reported FY26 record revenue of $429.2M (+11% YoY) and operating EBITDA of $67.0M (+11%), but operating NPAT fell 8% to $23.2M as legacy payday/vehicle loan runoff outpaced earnings from its new Cashies personal-loan book. The Cashies loan book grew nearly 5x to $114.1M (from $23.1M), with overall shares dropping 4.76% to $0.303 post-announcement on execution/timing concerns. Management guided FY27 toward funding/balance-sheet optimization and further store expansion, including 15–20 franchise acquisitions and 5–10 greenfield openings, with lending expected to be more earnings-contributive in FY28.

Analysis

The market is still pricing this like a legacy consumer lender, but the real sensitivity is shifting to store productivity and funding cost. That matters because the earnings bridge is no longer driven by loan spread alone; it is increasingly a retail roll-up story where incremental EBITDA can compound if acquisition multiples stay in the 4-5x range and integration holds. The setup favors a higher quality multiple over time, but only if the balance sheet can absorb the acquisition cadence without forcing expensive refinancing.

Near term, the main risk is a valuation air pocket: as the old book winds down faster than the new book seasons, reported NPAT can lag operating momentum for several quarters. That creates a classic “good fundamentals, weak reported earnings” trap, especially in a thinly traded microcap where one disappointing update can re-rate the stock sharply. Watch liquidity closely; the cash balance and facility headroom are adequate today, but they are not a cushion for an execution miss if deal flow slows or working capital tightens.

The contrarian angle is that the market may be over-discounting the transformation because it is anchoring on trailing profit rather than forward earnings power. Bad debt improvement plus lower regulatory stigma versus payday lending should improve the cost of capital over 6-18 months, which is the real optionality here. What would falsify the thesis is any sign that new loan origination growth stalls, store-level margins compress, or refinancing terms come in materially worse than management’s plan.

Second-order beneficiaries are likely adjacent circular-economy retailers and pre-owned luxury platforms if CCV validates that higher-ticket resale can scale with acceptable inventory turns. Losers are any remaining legacy credit-focused competitors with weaker compliance optics, because a cleaner platform mix should attract better capital and merchant partnerships. The immediate price weakness looks more like impatience than a broken story, but the stock needs proof by FY27 that operating EBITDA is translating into cash rather than just headline growth.

Key Decisions for Investors

• No aggressive chase on day-1 weakness; wait for 1-2 reporting periods of evidence that Cashies Loan growth is contributing to NPAT, not just top line, before initiating size.
• If building exposure, use a staged long in CCV on any pullback toward the lower end of its recent range, with a thesis duration of 6-12 months tied to refinancing and portfolio seasoning.
• Set a hard risk flag on facility renewal terms and net debt/cash movement; if funding spreads widen or cash falls faster than expected, cut the position as the M&A model becomes self-limiting.
• For higher-conviction market expression, pair a long CCV basket against a short in higher-regulatory-risk consumer credit names or payday proxies where applicable; the trade is a clean-vs-dirty balance sheet and optics spread over 3-6 months.
• Watch for a re-rating trigger only if operating NPAT resumes growth while store EBITDA and same-store sales remain strong; absent that, treat this as a hold/watch, not a buy-the-breakout.